Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) shares passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $27.39 and traded as low as $26.62. Otsuka shares last traded at $26.74, with a volume of 39,329 shares traded.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded Otsuka from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.
View Our Latest Research Report on Otsuka
Otsuka Price Performance
Otsuka Company Profile
Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
Read More
- Five stocks we like better than Otsuka
- Which Wall Street Analysts are the Most Accurate?
- Occidental Petroleum is a Buy in Q4 2025
- How to Invest in Blue Chip Stocks
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- 3 Best Fintech Stocks for a Portfolio Boost
- Amazon Is One of the Clearest Buys If the Market Dips Again
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
